The soaring demand for preclinical testing in China’s biotech sector has significantly boosted profits for laboratories breeding monkeys used in drug trials. Beijing-based Joinn Laboratories reported a staggering 1377.4% increase in first-half net profit, driven largely by rising prices for lab monkeys, particularly crab-eating macaques. Prices for these macaques have skyrocketed from around 90,000 yuan (approximately US$13,300) last year to as high as 200,000 yuan, reflecting a trend that began mid-2022. This surge is attributed to increasing demand for necessary preclinical testing in the biotech industry.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.scmp.com/economy/article/3360803/lab-monkey-prices-record-highs-chinas-biotech-boom-fuels-windfall-breeders
